Ibrance 00069-0688
Generic: Palbociclib
Product NDC
00069-0688- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 30, 2020
- Listing Expires
- December 31, 2027
- Application
- NDA212436
Need to source Ibrance? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Palbociclib | 125 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Cytochrome P450 3A Inhibitors [MoA]Kinase Inhibitor [EPC]
Packaging Options(1)
3 DOSE PACK in 1 CARTON (0069-0688-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0688-07)